Understanding cardiovascular disease is a complex and evolving process.Β
Is cholesterol itself the primary issue in coronary artery disease, or is it merely responding to underlying inflammation, autoimmunity, dysbiosis, or infection? Why do we need cholesterol in the first place? Is dietary cholesterol the main concern, or is it the type produced endogenously by the body? Could genetic mutations affect lipoprotein receptorsβwhich help clear cholesterol from the bloodstreamβplay a crucial role? Or is it a combination of many different factors?Β
These questions will be explored in more depth throughout this article.
[signup]
What is Coronary Artery Disease?
Coronary artery disease, also known as atherosclerosis, is the condition that ultimately leads to heart attacks. But what exactly is atherosclerosis? At its core, itβs an inflammatory process that starts in the arterial wall of the heartβs blood vessels, often at a very early age. Over many years, this process gradually narrows the coronary arteries, eventually culminating in what we recognize as a heart attack.Β
The term βatherosclerosisβ comes from two parts: βathero,β referring to a gruel-like or fatty substance, and βsclerosis,β indicating hardening. The resulting plaque is composed of cholesterol, lipids, immune cells (macrophages), fibrin, and calcium. This multifactorial etiology underscores the complexity of the disease.
Reevaluating Cholesterolβs Role in Heart Disease
Medical education in the 1990s taught that cholesterol was the root cause of heart disease and that lowering it would solve the problem. The reality is far more complex. Lipidologyβthe study of lipids and, therefore, atherosclerosisβis among the most intricate areas of cardiovascular science. Simply putting an adult on a cholesterol-lowering medication for primary prevention of a cardiovascular event is often insufficient. There must be more to the storyβand there is.
Seeking the true root causes of heart disease is especially important, as this condition is interwoven into the family histories of countless Americans. Early prevention is crucial, considering that atherosclerotic processes begin in infancy and continue throughout life. Before we dive deeper, itβs helpful to understand what cholesterol is and review studies detailing its functions and the roles of lipids in the human body.
Cholesterol: Essential Building Block and More
Cholesterol is a molecule critical for making steroid hormones, maintaining cell membranes, and producing bile acids and vitamin D. Itβs essential for human survival. While dietary sources from animal products add some cholesterol, most cholesterol is produced internallyβmainly in the liverβin response to low blood levels.Β
Plant foods contain phytosterols rather than cholesterol, and these plant sterols are not utilized by humans. Because cholesterol canβt move freely through the bloodstream, itβs transported by lipoproteins such as low-density lipoprotein (LDL). We can think of these lipoproteins as βcarsβ that carry cholesterol along our bodyβs βhighwaysβ to deliver this vital substance where itβs needed.
Lipoproteins: Transporters of Energy and Cholesterol
Lipoproteins, composed of fat and protein, carry both triglycerides (energy) and cholesterol. They transport triglycerides to various tissues, with cholesterol delivery often viewed as a secondary task. These carriers vary in size and composition.Β
The largest, known as chylomicrons (like βbusesβ), lose triglycerides and become smaller, denser LDL particles (like βcarsβ) as they deliver energy. LDL is often referred to as βbadβ cholesterol, but nothing in the human body is inherently βbadβ or βgood.β Rather, imbalances can turn something normally beneficial into a problem.
The Importance of Lipoprotein Particle Number
Recent research suggests that the number of LDL particles (LDL-P), as well as the level of apolipoprotein B (apo B) attached to these particles, is crucial in assessing heart disease risk.Β
When LDL particles are elevated, they create a concentration gradient that encourages cholesterol infiltration into the arterial wall, sparking plaque formation. Higher apo B and LDL-P values correlate with greater atherosclerotic risk. This understanding has refined our approach to cholesterol assessment.
Reframing the βGood or Badβ Lipid Debate
The prevailing hypothesis: Cholesterol and lipoproteins like LDL are inherently good and necessary unless genetic factors and/or lifestyle choices cause them to become unbalanced. Before we condemn LDL as purely harmful, itβs worth exploring why these lipoprotein βcarsβ evolved and how they serve protective roles in the body.
Lipoproteins and the Innate Immune System
Emerging evidence suggests that LDL and HDL particles are integral components of our innate immune system. For example, HDL particles have antimicrobial properties, helping protect against parasites and bacteria.Β
An inverse correlation exists between HDL levels and infection risk. Similarly, LDL appears to play a role in pathogen clearance.Β
Infection, Cholesterol, and Clinical Observations
Research supports the idea that lower cholesterol levels can sometimes predispose individuals to higher infection rates. For instance, one study associated LDL levels under 70 mg/dL with increased risks of hematological cancers, fever, and sepsis.Β
A 2019 study also noted that lower LDL levels were tied to a higher risk of sepsis and ICU admission among infected patients. While some attribute this to other illnesses, other models disagree.
Balancing Lipid Levels and Infection Risk
These findings raise the possibility that driving lipid levels too low might increase susceptibility to infections in certain patients. On the other hand, not all high cholesterol is harmful. Various populations and conditions donβt follow the simple βhigh cholesterol equals high riskβ rule.Β
About half of all heart attacks occur in people with βnormalβ cholesterol levels, highlighting that many other factorsβlike smoking, diabetes, hypertension, obesity, and air pollutionβare at play.
Inflammation at the Core
The common denominator in these risk factors is inflammation. While lowering LDL can be part of a strategy to reduce cardiovascular events, itβs not the entire solution. High-risk patients, especially those with previous heart attacks or strong family histories of early heart disease, may benefit from lowering apo B particle volumes. Yet, for many people, the underlying inflammatory processes and lifestyle factors are as critical as the lipid numbers themselves.
Genetics, Evolution, and the Infectious Environment
Genetic mutations like APOE4 or PCSK9 variants increase circulating lipoproteins. Historically, when infection posed a greater threat to survival than heart disease, these genetic traits might have been advantageous, allowing more effective clearance of pathogens.Β
Today, in a world of antibiotics and better sanitation, these once-beneficial adaptations may predispose us to heart disease if our lifestyle choices create chronic inflammation.
Gut Dysbiosis: The Hidden Trigger
Research into the human microbiome suggests that gut dysbiosisβan unhealthy gut bacterial environmentβcould be a significant driver of inflammation and lipid changes. Bacterial endotoxins like lipopolysaccharides (LPS) can enter the bloodstream, prompting the body to produce more lipoproteins to trap and remove these harmful molecules.Β
This response could explain why some individuals have elevated cholesterol: their bodies are responding to chronic, low-level infections or dysbiosis rather than just accumulating plaque βout of nowhere.β
Studies suggest in severe human infections, higher lipid levels correlate with better outcomes, indicating that lipoproteins serve as immediate responders in the immune systemβs fight against pathogens.Β
Chronic dysbiosis and dietary patterns that encourage low-grade infections can potentially lead to persistently elevated cholesterol as the body tries to manage ongoing threats. This can ultimately contribute to cardiovascular disease risk if left unchecked.Β
However, elevated cholesterol is often a sign of underlying issues like inflammation, gut imbalance, and lifestyle factorsβrather than an isolated cause of heart disease.
A More Nuanced Understanding of Cardiovascular Risk
This does not mean that elevated cholesterol levels are irrelevant; they still correlate with unfavorable cardiovascular outcomes. However, evidence suggests that high cholesterol is not necessarily the most significant upstream issue in coronary artery disease. Instead, it may serve as a marker of underlying imbalancesβsuch as gut dysbiosis, chronic infections, inflammation, and certain genetic predispositionsβthat drive the disease process over time.
In other words, inflammation, microbiome health, and long-term dietary habits often play larger roles than previously recognized. For example, individuals with autoimmune conditions face twice the risk of cardiovascular disease compared to those without such conditions.Β
These insights emphasize that while addressing lipoprotein levels is important, achieving truly effective prevention and management requires a more holistic approach. By focusing on reducing chronic inflammation, improving gut health, and considering genetic and lifestyle factors, we may move closer to genuine disease prevention and lasting heart health.
[signup]
Integrating Cholesterolβs Immune Role into the Bigger Picture
Now that we have a basic understanding of cholesterolβs potential immune functions, we can consider it as a marker of underlying chronic infectionβparticularly in the gut and oral cavityβas well as systemic inflammation and an enhanced cholesterol synthesis response in genetically susceptible individuals.Β
In those with certain single nucleotide polymorphisms (SNPs) affecting lipoprotein receptors or intestinal reabsorption, elevated cholesterol may not be effectively cleared by the liver or intestines once itβs upregulated. As a result, the persistently high levels of circulating cholesterol can create a concentration gradient that encourages lipoprotein infiltration into the arterial wall. Over time, through immune sensing, engulfment, and deposition, this process sets the stage for atherosclerotic events.
At this point, the conventional cardiovascular modelβwhich places elevated lipoproteins at the center of plaque formationβcomes into sharper focus. With a more complete understanding of cholesterolβs multifaceted role and the underlying triggers that lead to its abnormal accumulation, we are better equipped to interpret lab findings and appreciate their implications in a broader, more holistic clinical context.